Severe Persistent Pulmonary Hypertension of the Newborn Could serotonin hold answers for targeted therapies for PPHN?

Three decades after pioneering the treatment standard for persistent pulmonary hypertension of the newborn, our neonatologists have uncovered insights on serotonin that may lead to more targeted, effective therapies for patients with severe disease. #PPHN #NeoSky

Does IGF-1 LR3 Improve Growth in Placental Insufficiency? Explore effects of treatment on growth restricted fetal models.

A new preclinical study explored whether targeted biological therapies have the potential to effectively treat fetal growth restriction. #FetalHealth #metabolism #neonatology